Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions
NCT00834067
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Moexipril HCl/hydrochlorothiazide 15/25 mg tablets
DRUG:
UNIRETIC® 15/25 mg tablets
Sponsor
Teva Pharmaceuticals USA